You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High risk myelofibrosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)

Recruiting
  • Myelofibrosis
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 29, 2021

Moderate and High Risk Myelofibrosis Trial in China (TQ05105 tablets, Hydroxycarbamide tablets)

Recruiting
  • Moderate and High Risk Myelofibrosis
  • TQ05105 tablets
  • Hydroxycarbamide tablets
  • Beijing, Beijing, China
  • +3 more
Nov 23, 2021

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023

Myelofibrosis Trial in Paris (Ruxolotinib)

Completed
  • Myelofibrosis
  • Paris, France
    ROBIN
Jul 26, 2022

Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • +3 more
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Jun 11, 2021

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

Active, not recruiting
  • Myelofibrosis
  • Chronic Myelomonocytic Leukemia
  • Duarte, California
  • +9 more
Jan 24, 2023

Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Myelofibroses
  • Chicago, Illinois
    The University of Chicago
May 16, 2022

Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk

Recruiting
  • Myelofibrosis
  • +2 more
  • Hematopoietic stem cell transplant
  • +2 more
  • Calgary, Alberta, Canada
  • +4 more
Feb 16, 2021

Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +36 more
Jan 13, 2023

National Center for Precision Medicine in Leukemia

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Biobanking
  • (no location specified)
Jun 7, 2022

Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

Completed
Has Results
  • Myelofibrosis
  • Imetelstat 4.7 mg/kg
  • Imetelstat 9.4 mg/kg
  • Birmingham, Alabama
  • +71 more
Aug 17, 2021

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Study (MOST)

Completed
  • MPN (Myeloproliferative Neoplasms)
    • Huntsville, Alabama
    • +115 more
    May 11, 2022

    Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

    Recruiting
    • Myelofibrosis
    • La Jolla, California
    • +165 more
    Aug 19, 2022

    High Risk Pregnancy, Sexual Dysfunction, Anxiety Trial in Istanbul

    Recruiting
    • High Risk Pregnancy
    • +3 more
      • Istanbul, Sisli, Turkey
        Prof. Dr. Cemil Tascioglu City Hospital
      Nov 8, 2023

      Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

      Recruiting
      • Primary Myelofibrosis, Prefibrotic Stage
      • Myelofibrosis
      • Ropeginterferon alfa-2b
      • Hong Kong, Hong Kong
        Department of Medicine, the University of Hong Kong, Queen Mary
      Jul 25, 2021

      Ultra-high Risk for Psychosis, Clinical High Risk for Psychosis, At-risk Mental State Trial (Metacognitive Training)

      Not yet recruiting
      • Ultra-high Risk for Psychosis
      • +2 more
      • Metacognitive Training
      • (no location specified)
      Apr 23, 2023

      Pregnancy, High Risk Trial in Izmir (Motor imagery, Diaphragmatic breathing)

      Not yet recruiting
      • Pregnancy, High Risk
      • Motor imagery
      • Diaphragmatic breathing
      • İzmir, Turkey
        Health Sciences University İzmir Tepecik Education and Research
      Jul 12, 2023

      RISK FACTORS ASSOCIATED WITH HIGH ALTITUDE SICKNESS: A

      Recruiting
      • Acute Mountain Sickness
      • +2 more
        • Jomsom, Gandaki, Nepal
          Mustang District Hospital
        Sep 9, 2023

        High-Risk Percutaneous Coronary Intervention Trial in Tbilisi (The Elevate™ System)

        Active, not recruiting
        • High-Risk Percutaneous Coronary Intervention
        • The Elevate™ System
        • Tbilisi, Georgia
          Israeli-Georgian Medical Research Clinic "Helsicore"
        Oct 24, 2023